John A. Hey

Chief Tech/Sci/R&D Officer presso ALZHEON, INC.

64 anni

Health Technology

Consumer Services

Profilo

John A.
Hey is currently the Chief Scientific Officer at Alzheon, Inc. Prior to this, he was the Senior Director-Neurobiology at Schering-Plough Research Institute from 1988 to 2006.
He then served as the SVP-Discovery & Preclinical Drug Development at CoMentis, Inc. from 2006 to 2010, and as the Senior VP-Preclinical & Early Development at NormOxys, Inc. from 2010 to 2012.
Dr. Hey received his undergraduate degree from the University of Oklahoma.

Posizioni attive di John A. Hey

Società	Posizione	Inizio
ALZHEON, INC.	Chief Tech/Sci/R&D Officer	-

Tutte le posizioni attive di John A. Hey

Precedenti posizioni note di John A. Hey

Società	Posizione	Fine
NormOxys, Inc. NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA.	Corporate Officer/Principal	01/01/2012
CoMentis, Inc. CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01/01/2010
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Corporate Officer/Principal	01/01/2006

Vedi nel dettaglio l'esperienza di John A. Hey

Formazione di John A. Hey

University of Oklahoma

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John A. Hey

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
NormOxys, Inc. NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA.	Health Technology
Alzheon, Inc. Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA.	Health Technology
CoMentis, Inc. CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA.	Health Technology
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Health Technology

Vedi le connessioni aziendali